2 false false false false false false false false false false true false false false false false false No description of principal activity 2023-09-01 Sage Accounts Production Advanced 2024 - FRS102_2024 1,800 1,800 360 360 1,440 xbrli:pure xbrli:shares iso4217:GBP SC759997 2023-09-01 2024-09-30 SC759997 2024-09-30 SC759997 2023-08-31 SC759997 2023-02-23 2023-08-31 SC759997 2023-08-31 SC759997 2023-02-22 SC759997 core:NetGoodwill 2023-09-01 2024-09-30 SC759997 core:MotorVehicles 2023-09-01 2024-09-30 SC759997 bus:LeadAgentIfApplicable 2023-09-01 2024-09-30 SC759997 bus:Director1 2023-09-01 2024-09-30 SC759997 bus:Director2 2023-09-01 2024-09-30 SC759997 core:WithinOneYear 2024-09-30 SC759997 core:NetGoodwill 2024-09-30 SC759997 core:MotorVehicles 2024-09-30 SC759997 core:ShareCapital 2024-09-30 SC759997 core:ShareCapital 2023-08-31 SC759997 core:RetainedEarningsAccumulatedLosses 2024-09-30 SC759997 bus:SmallEntities 2023-09-01 2024-09-30 SC759997 bus:AuditExemptWithAccountantsReport 2023-09-01 2024-09-30 SC759997 bus:SmallCompaniesRegimeForAccounts 2023-09-01 2024-09-30 SC759997 bus:EntityHasNeverTraded 2023-09-01 2024-09-30 SC759997 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-09-30 SC759997 bus:FullAccounts 2023-09-01 2024-09-30 SC759997 core:ComputerEquipment 2023-09-01 2024-09-30 SC759997 core:ComputerEquipment 2024-09-30
COMPANY REGISTRATION NUMBER: SC759997
000 Medical Repatriation Ltd
Filleted Unaudited Financial Statements
30 September 2024
000 Medical Repatriation Ltd
Financial Statements
Period from 1 September 2023 to 30 September 2024
Contents
Page
Chartered accountants report to the board of directors on the preparation of the unaudited statutory financial statements
1
Statement of financial position
2
Notes to the financial statements
3
000 Medical Repatriation Ltd
Chartered Accountants Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements of 000 Medical Repatriation Ltd
Period from 1 September 2023 to 30 September 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of 000 Medical Repatriation Ltd for the period ended 30 September 2024, which comprise the statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of ICAS, we are subject to its ethical and other professional requirements which are detailed at www.icas.com/accountspreparationguidance. This report is made solely to the Board of Directors of 000 Medical Repatriation Ltd, as a body. Our work has been undertaken solely to prepare for your approval the financial statements of 000 Medical Repatriation Ltd and state those matters that we have agreed to state to you, as a body, in this report in accordance with the requirements of ICAS as detailed at www.icas.com/accountspreparationguidance. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than 000 Medical Repatriation Ltd and its Board of Directors, as a body, for our work or for this report.
It is your duty to ensure that 000 Medical Repatriation Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of 000 Medical Repatriation Ltd. You consider that 000 Medical Repatriation Ltd is exempt from the statutory audit requirement for the period. We have not been instructed to carry out an audit or a review of the financial statements of 000 Medical Repatriation Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
GILLILAND & COMPANY Chartered Accountants
216 West George Street Glasgow G2 2PQ
12 May 2025
000 Medical Repatriation Ltd
Statement of Financial Position
30 September 2024
30 Sep 24
31 Aug 23
Note
£
£
£
Fixed assets
Intangible assets
6
1,440
Tangible assets
7
18,793
--------
----
20,233
Current assets
Debtors
8
35,117
1
Cash at bank and in hand
2,676
--------
----
37,793
1
Creditors: amounts falling due within one year
9
54,146
--------
----
Net current (liabilities)/assets
( 16,353)
1
--------
----
Total assets less current liabilities
3,880
1
-------
----
Net assets
3,880
1
-------
----
Capital and reserves
Called up share capital
1
1
Profit and loss account
3,879
-------
----
Shareholders funds
3,880
1
-------
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 12 May 2025 , and are signed on behalf of the board by:
Mr J Quinn
Mrs AA Quinn
Director
Director
Company registration number: SC759997
000 Medical Repatriation Ltd
Notes to the Financial Statements
Period from 1 September 2023 to 30 September 2024
1. General information
The company is a private company limited by shares, registered in Scotland. The address of the registered office is 216 West George Street, Glasgow, G2 2PQ, Scotland.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Goodwill
-
20% straight line
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Motor vehicles
-
25% reducing balance
Equipment
-
33% straight line
Finance leases and hire purchase contracts
Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 2 (2023: Nil).
5. Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change of value.
6. Intangible assets
Goodwill
£
Cost
Additions
1,800
-------
At 30 September 2024
1,800
-------
Amortisation
Charge for the period
360
-------
At 30 September 2024
360
-------
Carrying amount
At 30 September 2024
1,440
-------
At 31 August 2023
-------
7. Tangible assets
Motor vehicles
Equipment
Total
£
£
£
Cost
At 1 September 2023
Additions
39,867
12,139
52,006
Disposals
( 28,541)
( 28,541)
--------
--------
--------
At 30 September 2024
11,326
12,139
23,465
--------
--------
--------
Depreciation
At 1 September 2023
Charge for the period
6,008
3,611
9,619
Disposals
( 4,947)
( 4,947)
--------
--------
--------
At 30 September 2024
1,061
3,611
4,672
--------
--------
--------
Carrying amount
At 30 September 2024
10,265
8,528
18,793
--------
--------
--------
At 31 August 2023
--------
--------
--------
8. Debtors
30 Sep 24
31 Aug 23
£
£
Trade debtors
1,790
Directors loan account
33,327
Other debtors
1
--------
----
35,117
1
--------
----
9. Creditors: amounts falling due within one year
30 Sep 24
31 Aug 23
£
£
Bank loans and overdrafts
729
Accruals and deferred income
2,000
Corporation tax
31,400
Social security and other taxes
665
Obligations under finance leases and hire purchase contracts
7,102
Other creditors
12,250
--------
----
54,146
--------
----
10. Directors' advances, credits and guarantees
As at 30th September 2024, the directors owed the company £33,327 (2023: £nil). Loan interest has been charged at 2.5% and the loan is unsecured with no fixed date of repayment.
11. Controlling party
The company was under the control of the directors throughout the period.